If you can deliver the same drug only into the cells where you want PPAR activation (the metabolically-active cells expressing GLP-1R or GIPR) and leave the rest of the bodys PPARs untouched, you have a chance of breaking the side-effect ceiling that has limited the entire class for two decades
Diabetes Care (2021) 44(3):76573
As of July 2025, the FDA got 605 adverse event reports tied to compounded semaglutide, but the real numbers probably higher
Mistake 4: not adjusting expectations for dose escalation periods Every dose increase brings temporary water retention, digestive changes, and altered eating patterns that can mask ongoing fat loss
Plastics derived endocrine disruptors (BPA, DEHP and DBP) induce epigenetic transgenerational inheritance of obesity, reproductive disease and sperm epimutations
At 5 mg/ml, 2.5 mg equals 0.50 ml